Song Liang, Li Qingli, Yang Kaixuan, Yin Rutie, Wang Danqing
The Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.
Medicine (Baltimore). 2018 Jun;97(24):e11107. doi: 10.1097/MD.0000000000011107.
Multiple primary malignancies can occur in the same organ or in multiple organs or systems. Likewise, they can occur simultaneously or successively. Based on the timing of the diagnosis, they are classified as multiple synchronous (i.e., concurrent) or metachronous (i.e., successive) primary malignancies. The vast majority of patients have multiple metachronous malignant tumors; multiple synchronous tumors are rare.
A 63-year-old woman presented with the chief complaint of vaginal fluid discharge for 3 months and abdominal pain for 1 month.
The patient was diagnosed with multiple synchronous primary malignancies: 1) endometrial poorly differentiated serous adenocarcinoma, stage IV; 2) poorly differentiated squamous cell carcinoma of the cervix, stage IB1; and 3) left-sided fallopian tube carcinoma in situ.
After total abdominal hysterectomy, bilateral salpingo-oophorectomy, and comprehensive staging and debulking, the patient was administered eight courses of adjuvant chemotherapy (taxane carboplatin/taxane cisplatin).
After chemotherapy completion, the patient has been undergoing regular follow-up examinations; no recurrence has been noted at 18 months.
It is important to distinguish between multiple synchronous primary malignancies and metastasis of a primary tumor to select the appropriate treatment regimen and to adequately assess the patient's prognosis. When a cancer patient shows clinical manifestations of another tumor, not only metastasis but also the possibility of multiple synchronous primary malignant tumors should be considered. The duration of follow-up in patients with malignant tumors should be extended as much as possible, as the timely detection and treatment of other primary malignant tumors can prolong survival and improve the quality of life.
多原发性恶性肿瘤可发生于同一器官或多个器官或系统。同样,它们可同时或相继发生。根据诊断时间,它们被分类为多原发性同时性(即并发)或异时性(即相继)恶性肿瘤。绝大多数患者有多原发性异时性恶性肿瘤;多原发性同时性肿瘤罕见。
一名63岁女性,以阴道分泌物增多3个月及腹痛1个月为主诉就诊。
患者被诊断为多原发性同时性恶性肿瘤:1)子宫内膜低分化浆液性腺癌,IV期;2)宫颈低分化鳞状细胞癌,IB1期;3)左侧输卵管原位癌。
在全腹子宫切除、双侧输卵管卵巢切除及全面分期减瘤术后,患者接受了8个疗程的辅助化疗(紫杉烷卡铂/紫杉烷顺铂)。
化疗完成后,患者一直在接受定期随访检查;18个月时未发现复发。
区分多原发性同时性恶性肿瘤和原发性肿瘤转移对于选择合适的治疗方案及充分评估患者预后很重要。当癌症患者出现另一肿瘤的临床表现时,不仅应考虑转移,还应考虑多原发性同时性恶性肿瘤的可能性。恶性肿瘤患者的随访时间应尽可能延长,因为及时发现和治疗其他原发性恶性肿瘤可延长生存期并提高生活质量。